Exagen to Announce Third Quarter Financial Results on November 10, 2026
Key Highlights
- ➤Exagen (XGN) will report third-quarter financial results before markets open November 10, 2026
- ➤CEO John Aballi and CFO Jeff Black will host an 8:00 a.m. ET results webcast
- ➤Webcast replay will remain available for 12 months on Exagen’s Investor Relations website
Expert Statements
John Aballi, President and Chief Executive Officer of Exagen Inc.
“will host a webcast at 8:00 a.m. ET (5:00 a.m. PT) that morning to review the results”
Jeff Black, Chief Financial Officer of Exagen Inc.
“will host a webcast at 8:00 a.m. ET (5:00 a.m. PT) that morning to review the results”
CARLSBAD, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended September 30, 2026, before the market opens on Tuesday, November 10, 2026. John Aballi, President and Chief Executive Officer, and Jeff Black, Chief Financial Officer, will host a webcast at 8:00 a.m. ET (5:00 a.m. PT) that morning to review the results.
The webcast will be available on the Exagen Investor Relations website at investors.exagen.com. Participants wishing to join by phone should register in advance using the following link for dial-in instructions: https://register-conf.media-server.com/register/BId7f4a0dc53154d5e84d4eb39ccfa279d.
Get started
Create a free account to read the full story.